Biography:
Dr. Xavier Le Guével obtained his PhD in 2006 in Chemistry from the University of Tours/ French Alternative Energies and Atomic Energy Commission (France). Following this, he did some postdoctoral fellowships in the fields of optical waveguides (Rome, Italy), biosensors (Dublin, Ireland) and pharmaceutical nanotechnology (Saarbrücken, Germany) between 2006 and 2010 before starting as an independent researcher at the Nanomedicine Centre Bionand in Malaga (Spain) in close collaboration with the department of Allergy at Malaga hospital.
Since 2016, XLG has been a CNRS researcher, and then CNRS research director since 2023 at the Institute for Advanced Biosciences at the University of Grenoble Alpes (France).
XLG was PI on various private and public funded projects (Plan cancer, ARC, ANR, LCC, Merck Serono, Carlos Tercero…) dedicated to the use of nanomaterials for diagnosis and therapy. His work focuses on the development of new nanosystems such as metal nanoclusters and optical instruments for medical applications and more specifically for cancer treatment and diagnosis from the fundamental research to pre-clinical applications.
